Abstract:It has been a great challenge to simultaneously inhibit the outgrowth of both the primary tumor and metastasis in metastatic cancer treatment. Substantial studies have evidenced that the interaction of platelets and cancer cells supports tumor metastasis, and platelets are considered to have metastasis-targeting property. Inspired by injury-targeting and metastasis-targeting properties of platelets, we constructed a photothermal therapy strategy with activated platelet-targeting albumin-based nanoparticles, PSN-HSA-PTX-IR780, to amplify drug delivery in the primary tumor at mild temperatures and simultaneously inhibit metastasis via a "platelet bridge". Human serum albumin (HSA) was premodified with a P-selectin-targeting peptide (PSN peptide) or IR780 serving as a photosensitizer. Hybrid albumin nanoparticles were assembled via the disulfide reprogramming method and encapsulated paclitaxel (PTX) to formulate PSN-HSA-PTX-IR780. The PSN-modified albumin nanoparticles could bind with upregulated P-selectin on activated platelets and subsequently target cancer cells by using platelets as a "bridge". In addition, nanoparticle-generated hyperthermia induced tissue injury and increased tumor-infiltrating platelets, thereby recruiting more nanoparticles into the tumor in a self-promoted way. In vivo studies showed that the drug accumulation of PSN-HSA-PTX-IR780 was 2.86-fold higher than that of HSA-PTX-IR780 at the optimal temperature (45 °C), which consequently improved the therapeutic outcome. Moreover, PSN-HSA-PTX-IR780 also effectively targets and inhibits lung metastasis by binding with metastasis-infiltrating platelets. Altogether, the self-promoted nanoplatform provides a unique and promising strategy for metastatic cancer treatment with enhanced drug delivery efficacy.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsami.1c04442?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsami.1c04442</a>.Synthesis route and 1H-NMR spectra of IR780SCOOH; 13C-NMR spectra and mass spectra; UV–vis–NIR absorbance and fluorescence emission spectra and temperature change curves of IR780 and IR780SCOOH; MALDI-TOF-MS spectra of HSA-IR780 and PSN-HSA; circular dichroism spectra; PTX release profiles; SEM images; cellular uptake of 4T1 cells; pharmacokinetic profiles; H&E staining images; hematology and blood biochemistry analysis (<a class="ext-link" href="/doi/suppl/10.1021/acsami.1c04442/suppl_file/am1c04442_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Palladium Nanoplates Scotch Breast Cancer Lung Metastasis by Constraining Epithelial-Mesenchymal Transition

Gd-metallofullerenol Nanomaterial As Non-Toxic Breast Cancer Stem Cell-Specific Inhibitor

Nanoplateletsomes Restrain Metastatic Tumor Formation Through Decoy and Active Targeting in a Preclinical Mouse Model.

Molecular Mechanism of Pancreatic Tumor Metastasis Inhibition by Gd@C82(OH)22 and Its Implication for De Novo Design of Nanomedicine.

Near‐Infrared Responsive Membrane Nanovesicles Amplify Homologous Targeting Delivery of Anti‐PD Immunotherapy Against Metastatic Tumors

Therapeutic Nanocarriers Inhibit Chemotherapy‐Induced Breast Cancer Metastasis

From Perinuclear to Intranuclear Localization: A Cell-Penetrating Peptide Modification Strategy to Modulate Cancer Cell Migration under Mild Laser Irradiation and Improve Photothermal Therapeutic Performance.

Leukocyte-Mimicking Pluronic-Lipid Nanovesicle Hybrids Inhibit The Growth And Metastasis Of Breast Cancer

Phenylboronic acid modified nanoparticles simultaneously target pancreatic cancer and its metastasis and alleviate immunosuppression

Systemic metastasis-targeted nanotherapeutic reinforces tumor surgical resection and chemotherapy

Activated Platelets‐Targeting Micelles with Controlled Drug Release for Effective Treatment of Primary and Metastatic Triple Negative Breast Cancer

Transformable self-delivered supramolecular nanomaterials combined with anti-PD-1 antibodies alleviate tumor immunosuppression to treat breast cancer with bone metastasis

PPy@Fe3O4 Nanoparticles Inhibit Tumor Growth and Metastasis Through Chemodynamic and Photothermal Therapy in Non-small Cell Lung Cancer.

Palladium Nanocapsules for Photothermal Therapy in the Near-Infrared II Biological Window

Transferrin-Modified Carprofen Platinum(IV) Nanoparticles as Antimetastasis Agents with Tumor Targeting, Inflammation Inhibition, Epithelial-Mesenchymal Transition Suppression, and Immune Activation Properties

Cisplatin prevents breast cancer metastasis through blocking early EMT and retards cancer growth together with paclitaxel

PD‐L1 Antibody‐Conjugated PAMAM Dendrimer Nanosystem for Simultaneously Inhibiting Glycolysis and Promoting Immune Response in Fighting Breast Cancer

Self-promoted Albumin-Based Nanoparticles for Combination Therapy against Metastatic Breast Cancer via a Hyperthermia-Induced “Platelet Bridge”

Herb-Nanoparticle Hybrid System for Improved Oral Delivery Efficiency to Alleviate Breast Cancer Lung Metastasis

Promising Colloidal Rhenium Disulfide Nanosheets: Preparation and Applications for In Vivo Breast Cancer Therapy

Anti-Tumor Metastasis via Platelet Inhibitor Combined with Photothermal Therapy under Activatable Fluorescence/Magnetic Resonance Bimodal Imaging Guidance